Administration of dexamethasone induces proteinuria of glomerular origin in mice

American Journal of Kidney Diseases

Volumn 31, Issue 3, 1998, Pages 443-452

  Chen, Ann ^a   Sheu, Lai Fa ^b   Ho, Yat Sen ^b   Lin, Yu Feng ^b   Chou, Wei Yuan ^b   Wang, Jia Yi ^b   Lee, Wei Hwa ^b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

Dexamthasone; Fibrinogen; Glomerulosclerosis; Heparin; Hyperfiltration; Nephrotoxi city; Proteinuria

Indexed keywords

DEXAMETHASONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORTICOSTEROID THERAPY; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION; MOUSE; NEPHROTOXICITY; NONHUMAN; PATHOGENESIS; PROTEIN URINE LEVEL; PROTEINURIA;

EID: 0031892423     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.1998.v31.pm9506681     Document Type: Article

References (63)

1. Heymann W, Grupe WE: Increase in proteinuria due to steroid medication in chronic renal disease. J Pediatr 74:356-363, 1969
2. Roscoe MH: The nephrotic syndrome. Q J Med 25:353-362, 1956
3. Dowdle E, Saunders S J: The acute effect of hydrocortisone sodium succinate on the proteinuria of the nephrotic syndrome. S Afr J Lab Clin Med 3:39-45, 1957
4. Hansten PD: Part II. Drug effects on clinical laboratory test results, in: Drug Interactions: Clinical Significance of Drug-Drug Interactions and Drug Effects on Clinical Laboratory Results (ed 4). Philadelphia, PA, Lea & Febiger, 1979, p 470
5. Hardin JG Jr: Steroid-induced morbidity mimicking active systemic lupus erythematosus. Ann Intern Med 78:558-560, 1973
6. Zager RA, Wimpfheimer B: Hyperalbuminuria: A pharmacologic effect of high-dose glucocorticoid administration. Curr Ther Res 26:568-574, 1979
7. Zager RA: Effects of glucocorticoid administration on urinary albumin excretion by the normal kidney. Renal Physiol 4:37-45, 1981
8. Chen A, Ding SL, Sheu LF, Song YB, Shieh SD, Shaio MF, Chou WY, Ho YS: Experimental IgA nephropathy: Enhanced deposition of glomerular IgA immune complex in proteinuric states. Lab Invest 70:639-647, 1994
9. Ginsberg JM, Chang BS, Matarese RA, Garella S: Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 309:1543-1546, 1983
10. Montinaro V, Hevey K, Aventaggiato L, Fadden K, Esparza A, Chen A, Finbloom DS, Rifai A: Extrarenal cytokines modulate the glomerular response to IgA immune complexes. Kidney Int 42:341-353, 1992
11. Huang TM, Chang GG: Characterization of the tetramer-dimer-monomer equilibrium of the enzymatically active subunits of pigeon liver malic enzyme. Biochemistry 31:12658-12664, 1992
12. 51Cr-edetic-acid complex. Lancet 1:818-819, 1967
13. Brien TG, O'Hagan R, Muldowney FP: Chromium-51-EDTA in the determination of glomerular filtration rate. Acta Radiol 8:523-529, 1969
14. 51Cr-EDTA biological half-life as an index of renal function. J Nucl Med 13:339-340, 1972
15. 51Cr-EDTA. Clin Sci 37:169-180, 1969
16. Knight JG, Adams DD, Purves HD: The genetic contribution of the NZB mouse to the renal disease of the NZBXNZW hybrid. Clin Exp Immunol 28:352-358, 1977
17. Chen A, Wei CH, Sheu LF, Ding SL, Lee WH: Induction of proteinuria by Adriamycin or bovine serum albumin in the mouse. Nephron 69:293-300, 1995
18. Schurer JW, Hoedemaeker PHJ, Molenaar I: Polyethyleneimine as tracer particle for (immuno) electron microscopy. J Histochem Cytochem 25:384-387, 1977
19. Beukers JJB, Hoedemaeker PJ, Weening JJ: A comparison of the effects of converting-enzyme inhibition and protein restriction in experimental nephrosis. Lab Invest 59:631-640, 1988
20. 2-microglobulin, albumin, and total protein. J Clin Invest 48:1189-1198, 1969
21. 2-microglobulin radioimmunoassays applied to monitoring of renal-allograft function and in differentiating glomerular and tubular diseases. Clin Chem 27:709-713, 1981
22. Woo KT, Lau YK, Wong KS, Lee GSL, Chin YM, Chiang GSC, Lim CH: Isoelectric focusing and selectivity index in IgA nephrotic syndrome. Nephron 67:408-413, 1994
23. Bertani T, Remuzzi G, Rocchi G, Delaini F, Sacchi G, Falchetti M, Donati MB: Steroids and Adriamycin nephrosis. Appl Pathol 2:32-38, 1984
24. Rich AR: A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bull Johns Hopkins Hosp 100:173-186, 1957
25. Kraus B, Cain H: Uber eine spontane Nephropathie bei Wistarratten. Virchows Arch A Pathol Anat Histopathol 363:343, 1974
26. Ikoma M, Yoshioka T, Ichikawa I, Fogo A: Mechanism of unique susceptibility of deep cortical glomeruli of maturing kidneys to severe focal glomerular sclerosis. Pediatr Res 28:270-276, 1990
27. Levett MF, Bader ME: Effect of cortisone and ACTH on fluid and electrolyte distribution in man. Am J Med 11:715-723, 1953
28. Pechet MM, Bowers B, Bartter FC: Metabolic studies with a new series of 1,4-diene steroids: II. Effects in normal subjects of prednisone, prednisolone, and 9-alpha-fluoropred-nisolone. J Clin Invest 38:691-701, 1959
29. Connell JMC, Whitworth JA, Davies DL, Lever AF, Richards AM, Fraser R: Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal man. J Hypertens 5:425-433, 1987
30. Dworkin LD, Hostetter TH, Rennke HG, Brenner BM: Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. J Clin Invest 73:1448-1461, 1984
31. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307:652-659, 1982
32. Meyer TW, Rennke HG: Progressive glomerular injury after limited renal infarction in the rat. Am J Physiol 254:F856-F862, 1988
33. Schwietzer G, Gertz KH: Changes of hemodynamics and glomerular ultrafiltration in renal hypertension of rats. Kidney Int 15:134-143, 1979
34. Brenner BM, Lawler EV, Mackenzie HS: The hyperfiltration theory: A paradigm shift in nephrology. Kidney Int 49:1774-1777, 1996
35. Rennke HG, Andersen S, Brenner BM: The progression of renal disease: Structural and functional correlations, in Tisher CC, Brenner BM (eds): Renal Pathology With Clinical and Functional Correlations (ed 2), vol 1. Philadelphia, PA, Lippincott, 1994, pp 118-119
36. Grond J, Koudstaal J, Elema JD: Mesangial function and glomerular sclerosis in rats with aminonucleoside nephrosis. Kidney Int 27:405-410, 1985
37. Mauer SM, Fish AJ, Blau EB, Michael AF: The glomerular mesangium: Kinetic study of macromolecular uptake in normal and nephrotic rats. J Clin Invest 51:1092-1101, 1972
38. Mauer SM, Fish AJ, Day NK, Michael AF: The glomerular mesangium. II. Studies of macromolecular uptake in nephrotoxic nephritis in rats. J Clin Invest 53:431-439, 1974
39. Couser WG, Jermanovich NB, Belok S, Stilmant MM, Hoyer JR: Effect of aminonucleoside nephrosis on immune complex localization in autologous immune complex nephropathy in rats. J Clin Invest 61:561-572, 1978
40. Bauman JW Jr: Corticoid effects on angiotensin- and norepinephrine-induced proteinuria in rats. Am J Physiol 237:F133-F137, 1979
41. Rosenberg RD, Darmus PS: The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem 248:6490-6505, 1973
42. Gervin AS: Complications of heparin therapy. Surg Gynecol Obstet 140:789-796, 1975
43. Nasjletti A, Maljk KU: Renal kinin-prostaglandin relationship: Implications for renal function. Kidney Int 19:860-868, 1981
44. Smith MC, Dunn MJ: Renal kallikrein, kinins, and prostaglandins in hypertension, in Brenner BM, Stein JH (eds): Hypertension: Contemporary Issues in Nephrology, vol 8. New York, NY, Churchill Livingstone, 1981, pp 168-202
45. Mandai AK, Oleinick SR, James TM, Wise W, Long H, Nordquist JA, Bell RD, Yunice AA, Parker D: Glomerular thrombosis in spontaneously hypertensive rat. II. Immunofluorescence microscopy. III. Effect of heparin. Microvasc Res 16:373-390, 1978
46. Susie D, Mandal AK, Kentera D: Heparin lowers the blood pressure in hypertensive rats. Hypertension 4:681-685, 1982
47. Susie D, Mandai AK, Radujkovic G, Vulovic D, Kentera D: Prostaglandin synthesis inhibitors potentiate the antihypertensive effect of heparin in spontaneously hypertensive rats. J Lab Clin Med 111:63-72, 1988
48. Susie D, Mandai AK, Kentera D: Hemodynamic effects of chronic alteration in hematocrit in spontaneously hypertensive rats. Hypertension 6:262-266, 1984
49. Yokokawa K, Mandal AK, Kohno M, Horio T, Murakawa K, Yasunari K, Takeda T: Heparin suppresses endothelin-1 action and production in spontaneously hypertensive rats. Am J Physiol 263:R1035-R1041, 1992
50. Jaques LB: Heparin: An old drug with a new paradigm. Science 206:528-533, 1979
51. Hiebert LM: Heparin and Endothelium in Heparin: Structure, Cellular Functions, and Clinical Applications. New York, NY, Academic Press, 1979, pp 289-297
52. Olson JL: Role of heparin as a protective agent following reduction of renal mass. Kidney Int 25:376-382, 1984
53. Purkerson ML, Joist JH, Greenberg JM, Kay D, Hoffsten PE, Klahr S: Inhibition by anticoagulant drugs of the progressive hypertension and uremia associated with renal infarction in rats. Thrombosis Research 26:277-240, 1982
54. Yu CP: Studies of steroid-induced hypertension in Wistar and Wistar/Furth rats. State University of New York at Buffalo, PhD Thesis, 1997
55. Eisenbach GM, Liew JB, Boylan JW, Manz N, Miur P: Effect of angiotensin on the filtration of protein in the rat kidney: A micropuncture study. Kidney Int 8:80-87, 1975
56. Bohrer MP, Deen WM, Robertson CR, Brenner BM: Mechanism of angiotensin II-induced proteinuria in the rat. Am J Physiol 233:F13-F21, 1977
57. Baumann JW Jr: On the mechanism of angiotensin-induced proteinuria. I. Studies in aminonucleoside nephrotic rats and in saralasin blockade. Nephron 27:47-50, 1981
58. Yoshioka T, Mitarai T, Kon V, Deen WM, Rennke HG, Ichikawa I: Role for angiotensin II in an overt functional proteinuria. Kidney Int 30:538-545, 1986
59. Yoshioka T, Rennke HG, Salant DJ, Deen WM, Ichikawa I: Role of abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: A study in early passive Heymann nephritis. Circ Res 61:531-538, 1987
60. Haakenstad AO, Case JB, Mannik M: Effect of cortisone on the disappearance kinetics and tissue localization of soluble immune complexes. J Immunol 114:1153-1160, 1975
61. Shvil Y, Mauer SM, Michael AF: Uptake of aggregated immunoglobulin by the mouse kidney. II. Effect of hydrocortisone. Br J Exp Pathol 61 :30-38, 1980
62. Germuth FG Jr, Valdes AJ, Senterfit LB, Pollack AD: A unique influence of cortisone on the transit of specific macromolecules across vascular walls in immune complex disease. Johns Hopkins Med J 122:137-153, 1968
63. Ward DM, Lee S, Wilson CB: Direct antigen binding to glomerular immune complex deposits. Kidney Int 30:706-711, 1986